This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Berenblum, I. Articles by Lonai, V. Search for Related Content PubMed PubMed Citation Articles by Berenblum, I. Articles by Lonai, V.

The Leukemogenic Action of Phorbol

Department of Experimental Biology, The Weizmann Institute of Science, Rehovot, Israel

The unesterified, water-soluble compound phorbol, which does not act as a promoting agent for skin carcinogenesis when applied topically (although phorbol esters extracted from croton seed oil display pronounced activity), was tested in female SWR mice for promoting action by the systemic route, in the hope of overcoming a suspected solubility barrier in the skin. The results were negative.

A high incidence of leukemias developed, however, both in the group receiving preliminary skin painting with 7,12-dimethylbenz(a)anthracene followed by phorbol injections and in the phorbol control group. The tumors were of lymphoid origin, mostly nonthymic. There were also many reticulum cell sarcomas in the phorbol-treated mice, but the incidence did not appear to be higher than in the control groups.

The potential value of phorbol as a chemical leukemogenic agent for the study of the mechanism of leukemogenesis is discussed.

Received 5/11/70. Accepted 7/14/70.

This article has been cited by other articles:

				D. Ishii, E Fibach, H Yamasaki, and I. Weinstein Tumor promoters inhibit morphological differentiation in cultured mouse neuroblastoma cells Science, May 5, 1978; 200(4341): 556 - 559. [Abstract] [PDF]